Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte

Exclusion Criteria

• •Any laser treatment on neck and/or chest within 12 months
• •Any topical treatment on neck and/or chest within 6 months
• •Pregnant and/or breastfeeding
• •Infection, dermatitis or a rash in the treatment area
• •Suffering from significant concurrent illness, such as Diabetes Mellitus or pertinent neurological disorders
• •History of seizure disorders due to light, fibromyalgia, connective tissue disease, vitiligo, psoriasis, pigmentary disorders, keloid scarring, hypertrophic scarring or abnormal wound healing
• •History of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications
• •Having a known anticoagulative condition or taking anticoagulation medications
• •History of diseases stimulated by heat, unless treatment is conducted following a prophylactic regimen
• •Having undergone any surgery in the treatment area within 6 months of treatment (or more if skin has not healed completely)
• •History of radiation to the head, neck and/or upper chest
• •Undergoing systemic chemotherapy for the treatment of cancer
• •Systemic use of isotretinoin (Accutane®) within 6 months
• •Any use of gold therapy
• •Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning during the study
• •Current smoker or history of smoking within 12 months of study
• •Participation in a study of another device or drug within 6 months
• •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in study